Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
about
Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer's DiseaseThere's Something Wrong with my MAM; the ER-Mitochondria Axis and Neurodegenerative DiseasesDissecting Alzheimer disease in Down syndrome using mouse modelsTargeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunitiesDynamics of Human Mitochondrial Complex I Assembly: Implications for Neurodegenerative DiseasesTau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brainSome evolutionary perspectives on Alzheimer's disease pathogenesis and pathologyDiabetes and Cognitive Impairment.Docking Studies and Biological Evaluation of a Potential β-Secretase Inhibitor of 3-Hydroxyhericenone F from Hericium erinaceus.Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failureThe intersection of amyloid beta and tau at synapses in Alzheimer's diseaseAlzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease.Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25-35 peptide-injected mice, a nontransgenic Alzheimer's disease model.Quantitative proteomics of delirium cerebrospinal fluid.Amyloid-Beta interaction with mitochondriaNeuroprotective strategies involving ROS in Alzheimer disease.The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro.Genetic variation of oxidative phosphorylation genes in stroke and Alzheimer's diseaseThe toxicity of tau in Alzheimer disease: turnover, targets and potential therapeuticsTau splicing and the intricacies of dementia.Modes of Aβ toxicity in Alzheimer's disease.Wheat germ agglutinin enhanced cerebral uptake of anti-Aβ antibody after intranasal administration in 5XFAD miceMitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicityTau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neuronsAcyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.Phosphorylation-dependent mitochondrial translocation of MAP4 is an early step in hypoxia-induced apoptosis in cardiomyocytes.Alzheimer's disease models and functional genomics-How many needles are there in the haystack?Soluble forms of tau are toxic in Alzheimer's disease.Mechanisms of tau and Aβ-induced excitotoxicity.TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3.What Renders TAU ToxicMitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasisCyanidin suppresses amyloid beta-induced neurotoxicity by inhibiting reactive oxygen species-mediated DNA damage and apoptosis in PC12 cells.Oxidative stress and the pathogenesis of Alzheimer's disease.Preservation of Cognitive Function by Lepidium meyenii (Maca) Is Associated with Improvement of Mitochondrial Activity and Upregulation of Autophagy-Related Proteins in Middle-Aged Mouse CortexTherapeutic potential of vaccines for Alzheimer's disease.Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.Metal attenuating therapies in neurodegenerative disease.Interaction between pathogenic proteins in neurodegenerative disorders.Long-term effects of ionising radiation on the brain: cause for concern?
P2860
Q26765824-37E4E704-A909-49BE-910C-786853EC1D77Q26768635-8455A5EA-E9BF-43D7-AB03-B672B5613D49Q26777254-BD6AB66F-B88D-40AD-BCD6-20CF2183B1B7Q27338799-F826C06F-347B-4F7E-BA7F-B4B41908508FQ28069775-2EE3A39D-2F13-4890-9352-FA84DEDE1B7EQ28116593-D9568717-2D6E-4EEC-B4B9-DFB74D2BF7B6Q28705398-D5E83AD7-F091-466F-8C2F-D023871A575AQ31119662-D94A9643-1857-40A4-A47F-B8BB0139B300Q33665730-AF3399AB-6771-4318-A5EB-E6BD5F431A04Q33680041-174140FE-09FD-4FD4-B38A-772B1913FF62Q34054680-FC559755-0B91-4CF9-AF1D-EF211718C11FQ34127614-4E29A340-7126-4C80-9A2F-8D722BBBB9BEQ34461389-481F6DBB-35CB-43B3-A49E-1AFD810E0F5FQ34657974-601AFB12-E1C1-4491-AE8B-97C741D4C9D0Q34725635-01E7EBAB-D734-4985-8074-8D0E25734FABQ34757939-38D15367-6B1C-4ECF-99CE-F31D49AC1670Q35020283-778949E3-DDE3-420B-94EA-D060EDD11C2AQ35086253-7CD808DC-B002-416D-AE80-940C97C204AAQ35216140-12C55FC9-CEF0-4D0F-93B8-101FB66AC2D5Q35226142-D00667D1-6FB7-4AF7-8CFD-DCFAF9D03714Q35235869-46E168E5-0C46-4873-BA2B-3434A631F2EDQ35300928-7C59CD4C-192D-4521-867C-20126318632AQ35579318-829B0867-4C1E-4ED4-AB65-85436570AB4EQ35642271-D2286F6A-88CE-40A1-A21D-4A059A7EC8DEQ35688942-A1857F59-39DC-4739-BA2F-FF444AB2B171Q35966171-439B3DB0-C22A-464B-B671-12A47BDAF145Q36193841-6577B95B-D4E7-42D4-A39B-B9EA856DA663Q36286360-ED672AE4-ED49-4F8C-AE60-4051AE4D9F4FQ36655783-E0B2A8C3-D060-49FC-B02B-DFA2A6C204CDQ36710234-DE7A2F5E-7A7A-4A50-8C04-04777067D151Q36914658-B6455025-00B4-4BF7-8972-B2A0ABCC63A7Q36960466-94E6A474-EE47-4A10-873D-8B8864099B71Q36996618-B76274D7-2C13-4E66-B72D-69678DE876BCQ37101305-2EC155A5-3964-4593-81ED-6EF9D3700421Q37246557-353F6C6F-6899-4FBA-94E5-C8414DFE781BQ37842339-33DE9C19-7086-4349-9E71-82AEBF6BF016Q37849615-BED67097-2030-4CC2-B085-35E27808DCB3Q37957126-3986F957-BF6A-41D6-A01B-2EA2BFD96509Q37969262-CE78CB26-1697-469B-BF76-87DE9C76397EQ38055706-0009A3AF-A056-4B5C-8703-9B924344F32C
P2860
Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
@ast
Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
@en
type
label
Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
@ast
Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
@en
prefLabel
Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
@ast
Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
@en
P2860
P921
P1476
Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
@en
P2093
Kathrin L Schulz
Virginie Rhein
P2860
P2888
P304
P356
10.1007/S12035-010-8109-5
P577
2010-03-09T00:00:00Z
2010-06-01T00:00:00Z
P5875
P6179
1025814271